Cargando…
High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms
Candidiasis is one of the most frequent nosocomial infections affecting an increasing number of at-risk patients. Candida albicans remains the most frequent causative agent of candidiasis, but, in the last decade, C. auris has emerged as a formidable multi-drug-resistant pathogen. Both species are f...
Autores principales: | Ajetunmobi, Olabayo H., Wall, Gina, Vidal Bonifacio, Bruna, Martinez Delgado, Lucero A., Chaturvedi, Ashok K., Najvar, Laura K., Wormley, Floyd L., Patterson, Hoja P., Wiederhold, Nathan P., Patterson, Thomas F., Lopez-Ribot, Jose L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532723/ https://www.ncbi.nlm.nih.gov/pubmed/37754987 http://dx.doi.org/10.3390/jof9090879 |
Ejemplares similares
-
Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis
por: Wiederhold, Nathan P., et al.
Publicado: (2019) -
1954. In vivo Efficacy of Delayed Therapy with the Novel Inositol Acyltransferase Inhibitor Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis
por: Wiederhold, Nathan P, et al.
Publicado: (2019) -
Antifungal therapy of Candida biofilms: Past, present and future
por: Ajetunmobi, Olabayo H., et al.
Publicado: (2023) -
Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation
por: Wall, Gina, et al.
Publicado: (2020) -
Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris
por: Zamith-Miranda, Daniel, et al.
Publicado: (2021)